Study investigated the role of micro-ribonucleic acid (miRNA) miR-335-5p as a potential therapeutic target for epilepsy.
Psychedelic-assisted drug developer MAPS PBC nabs $100M, renames to Lykos Therapeutics
MAPS Public Benefit Corporation, a California biotech attempting to bring MDMA-assisted therapy to market for mental health conditions, said it has raised more than $100